Capricor Therapeutics, Inc. (CAPR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$28.99
Day's range
$31.4

Capricor Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SUVRETTA CAPITAL MANAGEMENT, LLC 05/15/2026 3.82 M $116.09 M   113.85% 6.65%
BLACKROCK, INC. 05/13/2026 3.42 M $104.02 M   20.02% 5.96%
TANG CAPITAL MANAGEMENT LLC 05/15/2026 3.40 M $103.36 M   99.99% 5.92%
STATE STREET CORP 05/15/2026 2.18 M $66.33 M   163.03% 3.80%
VANGUARD CAPITAL MANAGEMENT LLC 05/15/2026 2.03 M $61.64 M   100.00% 3.53%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 1.51 M $45.84 M   0.00% 2.63%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.12 M $34.00 M   9.93% 1.95%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 1.05 M $31.97 M   -10.82% 1.83%
GOLDMAN SACHS GROUP INC 05/15/2026 911.98 K $27.72 M   103.57% 1.59%
JONES HILL CAPITAL LP 05/14/2026 909.21 K $27.64 M   100.00% 1.58%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 821.18 K $24.96 M   -55.37% 1.43%
FMR LLC 05/15/2026 772.65 K $23.49 M   -16.26% 1.35%
DIADEMA PARTNERS LP 05/15/2026 623.40 K $18.95 M   211.70% 1.09%
BOXER CAPITAL MANAGEMENT, LLC 05/15/2026 590.00 K $17.94 M   81.54% 1.03%
JANE STREET GROUP, LLC 05/12/2026 566.08 K $17.21 M   100.00% 0.99%
CITADEL ADVISORS LLC 05/15/2026 564.10 K $17.15 M   18.31% 0.98%
J. GOLDMAN & CO LP 05/15/2026 541.52 K $16.46 M   -9.05% 0.94%
CITADEL ADVISORS LLC 05/15/2026 539.23 K $16.39 M   -40.22% 0.94%
IKARIAN CAPITAL, LLC 05/15/2026 528.02 K $16.05 M   -8.65% 0.92%
MORGAN STANLEY 05/15/2026 423.82 K $12.88 M   -27.66% 0.74%
NORTHERN TRUST CORP 05/14/2026 417.54 K $12.69 M   19.08% 0.73%
BANK OF AMERICA CORP /DE/ 05/18/2026 415.48 K $12.63 M   672.00% 0.72%
MERCER GLOBAL ADVISORS INC /ADV 05/15/2026 403.00 K $12.25 M   100.00% 0.70%
DG CAPITAL MANAGEMENT, LLC 05/13/2026 392.10 K $11.92 M   -5.28% 0.68%
VANGUARD PORTFOLIO MANAGEMENT LLC 05/08/2026 379.21 K $11.53 M   100.00% 0.66%
UBS GROUP AG 05/05/2026 371.98 K $11.31 M   56.15% 0.65%
MILLENNIUM MANAGEMENT LLC 05/15/2026 356.35 K $10.83 M   -47.78% 0.62%
IKARIAN CAPITAL, LLC 05/15/2026 350.00 K $10.64 M   100.00% 0.61%
JPMORGAN CHASE & CO 05/13/2026 343.61 K $9.54 M   -6.91% 0.60%
CITADEL ADVISORS LLC 05/15/2026 336.50 K $10.23 M   -31.33% 0.59%
DIADEMA PARTNERS LP 05/15/2026 329.30 K $10.01 M   5.44% 0.57%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 320.10 K $9.73 M   100.00% 0.56%
D. E. SHAW & CO., INC. 05/15/2026 315.00 K $9.58 M   0.00% 0.55%
BARCLAYS PLC 05/15/2026 314.79 K $9.57 M   163.71% 0.55%
JANE STREET GROUP, LLC 05/12/2026 308.80 K $9.39 M   813.61% 0.54%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 297.12 K $9.03 M   -15.83% 0.52%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 259.90 K $7.90 M   -81.85% 0.45%
RTW INVESTMENTS, LP 05/15/2026 250.00 K $7.60 M   0.00% 0.44%
PALO ALTO INVESTORS LP 05/15/2026 229.76 K $6.98 M   1.53% 0.40%
MOODY ALDRICH PARTNERS LLC 04/20/2026 226.03 K $6.87 M   8.27% 0.39%
TREXQUANT INVESTMENT LP 05/15/2026 222.41 K $6.76 M   100.00% 0.39%
CAPTION MANAGEMENT, LLC 05/15/2026 221.80 K $6.74 M   -64.40% 0.39%
HBK SORCE ADVISORY LLC 05/11/2026 204.84 K $6.22 M   0.56% 0.36%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2026 200.00 K $6.08 M   100.00% 0.35%
RAYMOND JAMES FINANCIAL INC 05/14/2026 196.30 K $5.97 M   0.47% 0.34%
INVESCO LTD. 05/12/2026 185.37 K $5.64 M   1,260.93% 0.32%
QUINN OPPORTUNITY PARTNERS LLC 05/15/2026 178.38 K $5.42 M   -26.56% 0.31%
WALLEYE CAPITAL LLC 05/13/2026 177.54 K $5.40 M   100.00% 0.31%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 176.15 K $5.35 M   -7.65% 0.31%
NUVEEN, LLC 04/30/2026 162.91 K $4.95 M   79.11% 0.28%

Capricor Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 54 institutional investors and hedge funds held shares of Capricor Therapeutics Inc. The most heavily invested institutionals were:

TWO SIGMA INVESTMENTS, LP: 0

Engineers Gate Manager LP: 0

Mariner, LLC: 0

AXQ CAPITAL, LP: 0

Ally Bridge Group (NY) LLC: 0

Caitong International Asset Management Co., Ltd: 0

72.78% of Capricor Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 4.70 M shares in the last 24 months. This purchase volume represents approximately $143.86 M in transactions.